Successful autologous CD19 CAR T cell therapy following severe lupus flare during immunosuppressive washout in refractory lupus nephritis.

Evaluates the paradigm-shifting clinical efficacy of CD19-targeted CAR-T cell therapy for severe, refractory lupus nephritis.